WebMD Health Corp. (NASDAQ:WBMD) was downgraded by equities research analysts at Mizuho from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday. They presently have a $52.00 price objective on the stock, down from their previous price objective of $63.00. Mizuho’s price objective indicates a potential downside of 3.17% from the company’s previous close.
Several other analysts have also recently issued reports on the company. Leerink Swann restated a “buy” rating and set a $70.00 price objective on shares of WebMD Health Corp. in a research note on Tuesday, August 9th. Zacks Investment Research cut WebMD Health Corp. from a “hold” rating to a “sell” rating in a research note on Wednesday, July 20th. KeyCorp cut their price objective on WebMD Health Corp. from $74.00 to $72.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 16th. Citigroup Inc. upped their price objective on WebMD Health Corp. from $62.00 to $64.00 and gave the company a “neutral” rating in a research note on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. restated a “neutral” rating and set a $62.00 price objective on shares of WebMD Health Corp. in a research note on Thursday, August 11th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the company’s stock. WebMD Health Corp. currently has an average rating of “Buy” and a consensus price target of $64.29.
Shares of WebMD Health Corp. (NASDAQ:WBMD) traded down 0.20% on Wednesday, hitting $53.70. The company’s stock had a trading volume of 482,874 shares. WebMD Health Corp. has a 1-year low of $43.36 and a 1-year high of $67.55. The company has a 50 day moving average of $51.71 and a 200 day moving average of $56.20. The firm has a market cap of $2.02 billion, a PE ratio of 30.00 and a beta of 0.34.
WebMD Health Corp. (NASDAQ:WBMD) last issued its quarterly earnings results on Tuesday, November 1st. The company reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.07. WebMD Health Corp. had a return on equity of 35.64% and a net margin of 11.97%. The firm earned $171.40 million during the quarter, compared to the consensus estimate of $169.96 million. During the same quarter in the prior year, the business posted $0.32 earnings per share. WebMD Health Corp.’s revenue for the quarter was up 12.3% on a year-over-year basis. Equities analysts forecast that WebMD Health Corp. will post $1.91 EPS for the current year.
In other WebMD Health Corp. news, Chairman Martin J. Wygod sold 89,843 shares of the stock in a transaction on Monday, November 21st. The stock was sold at an average price of $53.94, for a total transaction of $4,846,131.42. Following the completion of the transaction, the chairman now directly owns 156,591 shares of the company’s stock, valued at approximately $8,446,518.54. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 8.10% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the stock. Meeder Asset Management Inc. purchased a new position in shares of WebMD Health Corp. during the first quarter worth about $115,000. LS Investment Advisors LLC raised its position in shares of WebMD Health Corp. by 7.2% in the third quarter. LS Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $123,000 after buying an additional 167 shares during the last quarter. BlackRock Inc. raised its position in shares of WebMD Health Corp. by 131.1% in the first quarter. BlackRock Inc. now owns 2,491 shares of the company’s stock worth $156,000 after buying an additional 1,413 shares during the last quarter. Advisory Services Network LLC purchased a new position in shares of WebMD Health Corp. during the third quarter worth about $201,000. Finally, Aperio Group LLC raised its position in shares of WebMD Health Corp. by 2.1% in the third quarter. Aperio Group LLC now owns 4,151 shares of the company’s stock worth $206,000 after buying an additional 87 shares during the last quarter. 84.44% of the stock is owned by hedge funds and other institutional investors.
About WebMD Health Corp.